Target ALS raises $250 million to accelerate ALS research – ALS News Today In the News | News Share Funding will be applied toward research into biomarkers, ALS therapies. Read the article Read the original press release
Driving Urgency and Hope: Dr. Björn Oskarsson on Biofluids, Biomarkers, and the Future of ALS Research
Target ALS Highlighted in New Case Study Released by Harvard Kennedy School Focused on Innovative Model for Collaborative Medical Research